Tonix Pharmaceuticals Holding (TNXP) Total Debt (2010 - 2024)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Total Debt of $7.5 million for Q4 2024, down 15.98% year-over-year from $8.9 million in Q1 2024, and down 6.32% quarter-over-quarter from $8.0 million in Q3 2024.
Tonix Pharmaceuticals Holding (TNXP) Total Debt (2010 - 2024) Analysis & Trends
Tonix Pharmaceuticals Holding's Total Debt history runs 4 years deep, the most recent figure standing at $7.5 million for Q4 2024.
- In Q4 2024, Total Debt fell 15.98% year-over-year to $7.5 million; the TTM figure through Dec 2024 stood at $7.5 million (down 15.98% YoY), while the FY2024 annual figure was $7.5 million, down 15.98% from the prior year.
- Total Debt for Q4 2024 stood at $7.5 million, down from $8.0 million in the prior quarter.
- The five-year high for Total Debt was $9.0 million in Q1 2024, with the low at $7.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 7.99 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 8.91 Mn |
| Dec 31, 2011 | 150,000.00 |
| Sep 30, 2011 | 10,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 10,000.00 |